Skip to main content
Move the World.
Why Don’t Vaccines Work as Well in Poor Countries?

Lead image by Pete Lewis / UK Department forInternational Development

Vaccination has been a powerful tool for stopping contagious diseases for two centuries, and scientists are working hard on new vaccines for diseases like HIV and malaria. But there's a lot that could still be done with our existing technology: 3 million people (including over a million children) die each year from vaccine-preventable diseases, mostly concentrated in poor countries.

Unfortunately, while vaccines tend to work extremely well in the developed world, they are much less effective elsewhere. This mystery has puzzled scientists and frustrated health organizations for years, but a new study may have found the answer. Common diseases in the developing world, like TB and malaria, can damage lymph nodes and trigger chronic inflammation, making people more susceptible to infection and less responsive to vaccines. This finding could be crucial to unlocking the benefits of immunity for both new and existing vaccines throughout the world.

The Good News: Many contagious diseases have been eradicated or battered to the fringes of wealthy countries, in large part thanks to highly effective vaccinations. Most of our commonly used vaccines are about 90% effective in high-income countries (meaning that vaccinated people are 90% less likely to get sick if they're exposed to an infection). It's very hard for a disease to spread itself in a population where everyone is walking around with 90% shields, and that makes it easier to control outbreaks.

A Double Whammy: But those efficacy rates never seem to translate to impoverished countries, where you're not only more likely to encounter such diseases but also much more likely to die from any kind of illness. It's especially valuable to not get sick in the first place if you're much more likely to die when you do. But, perversely, the vaccine shield is much less effective in the place where it is most needed.

Take rotavirus: this disease causes severe vomiting, diarrhea, abdominal pain, and dehydration, and it kills over 200,000 people a year (almost exclusively children). Studies show that the rotavirus vaccines are 80-90% effective in high-income countries, but only 40-60% in low-income countries. Not only are you more likely to get sick individually, the virus will have an easier time spreading, and the country will need even more people to be vaccinated to slow an outbreak. That's already going to be hard to do in poor and remote areas, while a 40% shield is just logically less appealing than a 90% shield.

Why the "Immune Inequality"? Vaccines stimulate the immune system to make antibodies for certain diseases, priming the body to recognize it and fight it off. But if your immune system isn't running at full capacity—like, for instance, the very old, the very young, chemo patients, people who are already sick, and people with autoimmune diseases or HIV—your body might not respond to the vaccine. There's a few reasons why people in poor countries might in general have lower immunity, including worse nutrition, parasites, and chronic infections. But until now, there's been little study of exactly how this happens.

These data have important implications for how vaccines are designed and tested... This especially true of vaccines for HIV, malaria, and TB.

Dr. Tim SchackerUniversity of Minnesota Medical School

The Experiment: Researchers at the University of Minnesota thought that other common infections in the developing world, like malaria and TB, could be damaging people's immune systems and therefore reducing vaccine effectiveness. They compared the immune systems of groups of Americans and Ugandans and found that the Ugandans had more inflammation, fewer T cells (the "soldiers of the immune system"), and significant physical damage to their lymph nodes, where vaccine responses are triggered.

Chronic inflammation caused scarring and thickening in their lymph nodes, likely as the result of diseases endemic to central Africa. Researchers gave both groups a vaccine for yellow fever (yeah, that's still a thing) and found that the Ugandans made much fewer antibodies. Plus, their responsiveness to the vaccine was correlated with the degree of inflammation and lymphatic damage, further suggesting a direct or causal connection.

The Upshot: Like a lot of scientific discoveries, the immediate impact of this finding is hard to predict. Assuming it is replicated with other vaccines and other countries, one thing it suggests is that there's an even bigger upside for controlling diseases like TB and malaria, because the secondary consequence would be a general improvement in immunity against a bunch of other unrelated diseases. But it could also help guide scientists to create new versions of vaccines that work better in populations with more limited immune responses.

Up Next

Dope Science
Legal Pot Is Finally Growing Up and Going to College
cannabis degree program
Dope Science
Legal Pot Is Finally Growing Up and Going to College
As medical marijuana becomes mainstream, so does the need for an educated workforce in the industry. Enter the nation's first-ever cannabis degree program.

As medical marijuana becomes mainstream, so does the need for an educated workforce in the industry. Enter the nation's first-ever cannabis degree program.

Global Impact
Conversations with Refugees
Conversations with Refugees
Global Impact
Conversations with Refugees
Aline Sara is changing the conversation around what it means to be a refugee by talking — literally. Through her...

Aline Sara is changing the conversation around what it means to be a refugee by talking — literally. Through her startup, NaTakallam (Arabic for "we talk"), Aline pairs refugees with people from other countries who want to learn their language. The "conversation partners" chat over Whatsapp or Skype to improve their Arabic or Spanish. But Aline says that people gain more than just language skills: it is foreign language...

Thinking Differently
Is Autism a Mysterious Medical Condition or Part of the Spectrum of Human Diversity?
Is Autism a Mysterious Medical Condition or Part of the Spectrum of Human Diversity?
Thinking Differently
Is Autism a Mysterious Medical Condition or Part of the Spectrum of Human Diversity?
Rethinking Autism: Interview with NeuroTribes Author Steve Silberman

Rethinking Autism: Interview with NeuroTribes Author Steve Silberman

#FIXINGJUSTICE - harm reduction
24 Years For a Crime He Didn’t Commit
24 Years For a Crime He Didn’t Commit
Watch Now
#FIXINGJUSTICE - harm reduction
24 Years For a Crime He Didn’t Commit
When a prisoner serving a life sentence is suddenly found to be innocent, it often makes national news. But what happens after the cameras go away?
Watch Now

There are around 2,500 exonerees in the U.S.—people who were convicted of a crime and then later proven innocent by their own doggedness or new evidence in a case. When they are freed from prison, their lives are often saddled by the same issues that hold back people who actually committed a crime—lack of education, no job skills or employment history, and the stigma of having spent years in prison. While their release is...

#fixingjustice - Policing
Civilian Oversight Is a Solution to Police Misconduct. But is it Effective?
civilian oversight
#fixingjustice - Policing
Civilian Oversight Is a Solution to Police Misconduct. But is it Effective?
Creating a civilian review board to oversee police conduct seems like a straightforward solution to disciplinary...
By Andrew Denney

Creating a civilian review board to oversee police conduct seems like a straightforward solution to disciplinary issues on the force. But why is it so hard to implement?

Teaser of The Hidden Side of “Slum” Life
Teaser of The Hidden Side of “Slum” Life
Watch Now
Teaser of The Hidden Side of “Slum” Life
One of the most significant transformations in humankind is underway but largely going untold.
Watch Now

One of the most significant transformations in humankind is underway but largely going untold. Fueled by advances in technology and innovation, global poverty has been slashed in half over the last decade with predictions that it will be eradicated over the next. From makeshift cities to smart phones to water purification to the blockchain, join us as we travel the world to see firsthand how entrepreneurship is lifting...

On The Cusp
This Week in Ideas: Saying Goodbye to Lab Rats and Replacing Bees with Drones
This Week in Ideas: Saying Goodbye to Lab Rats and Replacing Bees with Drones
On The Cusp
This Week in Ideas: Saying Goodbye to Lab Rats and Replacing Bees with Drones
Breakthrough could mean the end of test animals, violent crime nearly cut in half, and drones that pollinate flowers.
By Michael O'Shea

Breakthrough could mean the end of test animals, violent crime nearly cut in half, and drones that pollinate flowers.